Thank you for donating!

You can donate using the following services.

Where to Find Additional Support

More Assistance

You’ll find an extensive list of organisations and services over at the Useful Resources and Linkssection of this site…as the name suggests they can be rather handy, and may be of great assistance to you!

But please remember: we want this site to be a place where information is easily accessible, and also understandable – so if that is ever not the case, don’t hesitate to get in touch with us so that we can talk you through anything complicated. We will do everything in our power to help you.

shot-248-1

For instance:

  • Our Families Officer can help you to locate the services and support available to you in your local area, and can also provide advice regarding housing, benefits, and education.
  • Our Clinical Nurse Specialist can direct you to your local health care services, or liaise with your health and social care team, which may include your Occupational Therapist, Speech and Language Therapist or Social Worker.
  • And the good people at our Central Office can use their experience and expertise to provide comprehension on the range of information you will be faced with – as well as lending a comforting ear whenever you may need it.

We are always just a phone call (0191 415 0693) or email (info@npuk.org) away. So you needn’t ever feel lost or disillusioned as you always have a friend in NPUK.

(Keeping a record of the people who help you can make it easier to get support when you need it.  Try to keep a list of their contact details handy – or get in touch with us and we will provide you with all we have!)

 

Latest news

29.11.19

#ChildrenAtTheHeart

We are joining 140+ organisations in a call to all political parties to put children and young people at the heart of this General Election...

Read more

19.11.19

Orphazyme receives Breakthrough Therapy Designation for arimoclomol in Niemann-Pick Disease Type C (NPC)

Kim Stratton, Chief Executive Officer at Orphazyme, commented, “We are delighted with FDA’s decision to grant Breakthrough Therapy Designation to arimoclomol for NPC. Arimoclomol has been shown to have a clinically meaningful effect on disease progression in NPC that is further supported by a biomarker effect indicating an effect on the biological underpinnings of the disease and a favorable safety and tolerability profile. We are committed to bringing this product to patients as soon as possible. Breakthrough Therapy Designation is designed to expedite the development and review of products for serious diseases with the direct involvement of senior staff and we look forward to working closely with the FDA to further advance arimoclomol. Our preparations for filing in the US are underway and we are on track to submit a New Drug Application in H1 2020.”

Read more
View all news Subscribe